Hap Trading, LLC Acadia Pharmaceuticals Inc Transaction History

Hap Trading, LLC

  • $840 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$16.79 - $27.09 $253,478 - $408,977
-15,097 Closed
0 $0
Q3 2021

Nov 10, 2021
SELL
$15.78 - $24.77 $1.06 Million - $1.67 Million
-67,340 Reduced 81.69%
15,097 $251,000
Q2 2018

Aug 13, 2018
BUY
$15.07 - $22.34 $1.24 Million - $1.84 Million
82,437 New
82,437 $1.26 Million

Others Institutions Holding ACAD

# of Institutions
288
Shares Held
161M
Call Options Held
723K
Put Options Held
257K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email